Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination

Clin Exp Dermatol. 2022 Feb;47(2):428-432. doi: 10.1111/ced.14926. Epub 2021 Oct 10.

Authors

K Wantavornprasert¹, N Noppakun¹, J Klaewsongkram², P Rerknimitr¹

Affiliations

¹ Division of Dermatology, Skin and Allergy Research Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
² Division of Allergy and Clinical Immunology, Skin and Allergy Research Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
COVID-19 / prevention & control*
ChAdOx1 nCoV-19 / adverse effects*
Drug Eruptions / etiology*
Drug Eruptions / pathology
Humans
Male
SARS-CoV-2

Substances

ChAdOx1 nCoV-19